Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study

(2013) Hideki Ueno et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gemcitabine Plus Capecitabine in Unselected Patients With Advanced Pancreatic Cancer

(2013) Richard A. Hubner et al.   PANCREAS

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

(2012) Y Nakai et al.   BRITISH JOURNAL OF CANCER

Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)

(2012) Masato Ozaka et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials

(2012) Domenico Ciliberto et al.   EUROPEAN JOURNAL OF CANCER

Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial

(2012) Sophie Gourgou-Bourgade et al.   JOURNAL OF CLINICAL ONCOLOGY

Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

(2012) Chen Sun   WORLD JOURNAL OF GASTROENTEROLOGY

A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer

(2012) Jong Gwon Choi et al.   Cancer Research and Treatment

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma

(2011) Jing Hu et al.   Journal of Hematology & Oncology

Gemcitabine-based Cytotoxic Doublets Chemotherapy for Advanced Pancreatic Cancer: Updated Subgroup Meta-analyses of Overall Survival

(2010) D. r. Xie et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Capecitabine-based chemotherapy for metastatic colorectal cancer

(2010) Wei Ling et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

S-1: a promising new oral fluoropyrimidine derivative

(2009) Muhammad Wasif Saif et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

(2009) David Cunningham et al.   JOURNAL OF CLINICAL ONCOLOGY

Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis

(2009) Bernardo HL Goulart et al.   Journal of Hematology & Oncology

Gemcitabine versus Gemcitabine Combined with Cisplatin Treatment Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Analysis

(2009) Jae-Hyuk Choi et al.   Cancer Research and Treatment

Development History and Concept of an Oral Anticancer Agent S-1 (TS-1(R)): Its Clinical Usefulness and Future Vistas

(2008) T. Shirasaka   JAPANESE JOURNAL OF CLINICAL ONCOLOGY